361 related articles for article (PubMed ID: 17347896)
41. Morbidity of prophylactic lymph node dissection in the central neck area in patients with papillary thyroid carcinoma.
Henry JF; Gramatica L; Denizot A; Kvachenyuk A; Puccini M; Defechereux T
Langenbecks Arch Surg; 1998 Apr; 383(2):167-9. PubMed ID: 9641892
[TBL] [Abstract][Full Text] [Related]
42. Short and Long-Term Potential Role of Carbon Nanoparticles in Total Thyroidectomy with Central Lymph Node Dissection.
Xue S; Ren P; Wang P; Chen G
Sci Rep; 2018 Aug; 8(1):11936. PubMed ID: 30093623
[TBL] [Abstract][Full Text] [Related]
43. Central neck dissection for papillary thyroid cancer.
Hughes DT; Doherty GM
Cancer Control; 2011 Apr; 18(2):83-8. PubMed ID: 21451450
[TBL] [Abstract][Full Text] [Related]
44. Performing contralateral central lymph node dissection in papillary thyroid carcinoma: a decision approach.
Chae BJ; Jung CK; Lim DJ; Song BJ; Kim JS; Jung SS; Bae JS
Thyroid; 2011 Aug; 21(8):873-7. PubMed ID: 21745104
[TBL] [Abstract][Full Text] [Related]
45. Impact of prophylactic central neck dissection on oncologic outcomes of papillary thyroid carcinoma: a review.
Mamelle E; Borget I; Leboulleux S; Mirghani H; Suárez C; Pellitteri PK; Shaha AR; Hamoir M; Robbins KT; Khafif A; Rodrigo JP; Silver CE; Rinaldo A; Ferlito A; Hartl DM
Eur Arch Otorhinolaryngol; 2015 Jul; 272(7):1577-86. PubMed ID: 25022716
[TBL] [Abstract][Full Text] [Related]
46. Does failure to perform prophylactic level VI node dissection leave persistent disease detectable by ultrasonography in patients with low-risk papillary carcinoma of the thyroid?
Monchik JM; Simon CJ; Caragacianu DL; Thomay AA; Tsai V; Cohen J; Mazzaglia PJ
Surgery; 2009 Dec; 146(6):1182-7. PubMed ID: 19958947
[TBL] [Abstract][Full Text] [Related]
47. Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection.
Ito Y; Higashiyama T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Miyauchi A
World J Surg; 2007 Nov; 31(11):2085-91. PubMed ID: 17885787
[TBL] [Abstract][Full Text] [Related]
48. Indications and extent of central neck dissection for papillary thyroid cancer: An American Head and Neck Society Consensus Statement.
Agrawal N; Evasovich MR; Kandil E; Noureldine SI; Felger EA; Tufano RP; Kraus DH; Orloff LA; Grogan R; Angelos P; Stack BC; McIver B; Randolph GW
Head Neck; 2017 Jul; 39(7):1269-1279. PubMed ID: 28449244
[TBL] [Abstract][Full Text] [Related]
49. [Surgical treatment of recurrent thyroid carcinoma after primary resection].
Kohara N; Furui J; Tomioka T; Motojima K; Tsunoda T; Kanematsu T
Nihon Geka Gakkai Zasshi; 1993 Aug; 94(8):847-52. PubMed ID: 8377761
[TBL] [Abstract][Full Text] [Related]
50. Central neck lymph node dissection for papillary thyroid cancer: the reliability of surgeon judgment in predicting which patients will benefit.
Shen WT; Ogawa L; Ruan D; Suh I; Duh QY; Clark OH
Surgery; 2010 Aug; 148(2):398-403. PubMed ID: 20451230
[TBL] [Abstract][Full Text] [Related]
51. Right Central Lymph Node Dissection in Thyroidectomy: Can Endoscopic Chest-Breast Approach Be Used?
Sun P; Chen W; Mak TK; Chong TH; Li J; Yang J; Wang C
J Laparoendosc Adv Surg Tech A; 2020 Mar; 30(3):308-314. PubMed ID: 31746665
[No Abstract] [Full Text] [Related]
52. Ipsilateral versus bilateral central neck lymph node dissection in papillary thyroid carcinoma.
Moo TA; Umunna B; Kato M; Butriago D; Kundel A; Lee JA; Zarnegar R; Fahey TJ
Ann Surg; 2009 Sep; 250(3):403-8. PubMed ID: 19661784
[TBL] [Abstract][Full Text] [Related]
53. Should central lymph node dissection be considered for all papillary thyroid microcarcinoma?
Chang YW; Kim HS; Kim HY; Lee JB; Bae JW; Son GS
Asian J Surg; 2016 Oct; 39(4):197-201. PubMed ID: 25913730
[TBL] [Abstract][Full Text] [Related]
54. The risk of hypoparathyroidism after central compartment lymph node dissection in the surgical treatment of pT1, N0 thyroid papillary carcinoma.
Aydin OU; Soylu L; Ozbas S; Ilgan S; Bilezikci B; Gursoy A; Sengezer T; Kocak S
Eur Rev Med Pharmacol Sci; 2016 May; 20(9):1781-7. PubMed ID: 27212170
[TBL] [Abstract][Full Text] [Related]
55. [The role of lymphadenectomy in the treatment of differentiated thyroid cancer].
Dănilă R; Popovici R; Andriescu L; Timofte D; Ungureanu MC; Găluşcă B; Dragomir C
Rev Med Chir Soc Med Nat Iasi; 2007; 111(1):129-34. PubMed ID: 17595858
[TBL] [Abstract][Full Text] [Related]
56. Outcomes of total thyroidectomy with therapeutic central and lateral neck dissection with a single dose of radioiodine in the treatment of regionally advanced papillary thyroid cancer and effects on serum thyroglobulin.
Hughes DT; Miller BS; Cohen MS; Doherty GM; Gauger PG
Ann Surg Oncol; 2014 May; 21(5):1647-52. PubMed ID: 24385210
[TBL] [Abstract][Full Text] [Related]
57. The clinical prognosis of patients with cN0 papillary thyroid microcarcinoma by central neck dissection.
Zhang L; Liu Z; Liu Y; Gao W; Zheng C
World J Surg Oncol; 2015 Apr; 13():138. PubMed ID: 25889385
[TBL] [Abstract][Full Text] [Related]
58. Prophylactic central neck dissection and local recurrence in papillary thyroid microcarcinoma: a meta-analysis.
Su H; Li Y
Braz J Otorhinolaryngol; 2019; 85(2):237-243. PubMed ID: 30017872
[TBL] [Abstract][Full Text] [Related]
59. Lateral lymph node metastasis in papillary thyroid carcinoma: results of therapeutic lymph node dissection.
Chung YS; Kim JY; Bae JS; Song BJ; Kim JS; Jeon HM; Jeong SS; Kim EK; Park WC
Thyroid; 2009 Mar; 19(3):241-6. PubMed ID: 19265495
[TBL] [Abstract][Full Text] [Related]
60. [Lymph node dissection in non-medullary differentiated thyroid carcinoma].
Mathonnet M
Ann Chir; 2006; 131(6-7):361-8. PubMed ID: 16329987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
